HUMA (Humacyte Inc) שולי רווח גולמי

סמל תאגידי ולוגו של Humacyte Inc (HUMA)

Humacyte, Inc. (HUMA) independently produces bioengineered tissues while sourcing raw materials from external partners. The gross margin indicator provided by GURU.Markets recorded the metric at -623.00. Outsourcing logistics and testing to contractors allows the company to focus on research and development. The business is currently transitioning from the research stage to the mass commercial production of innovative HAV vessels.

Humacyte Corp (HUMA): רווחיות לפי רווח גולמי מ-04.07.2022 עד 19.11.2026

פילוחי מדדים פיננסיים ומדדי שוק עבור Humacyte Inc (HUMA)

- מחיר ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
ניתוח מסכם של החברה:Humacyte (HUMA)
סחורת הדגל של Humacyte

The assessment of Humacyte, Inc. (HUMA) margin of safety is based on gross margin, which determines the profit share after deducting direct production costs, reflecting the efficiency of cost management. By analyzing gross margin dynamics, an investor can identify profitability risks driven by technological complexities in scaling the production of biosynthetic tissues and delays in regulatory product approval.